| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cancer Research Campaign Laboratories, Department of Cancer Studies, University of Birmingham, Birmingham B15 2TJ, U.K.
Epstein—Barr virus (EBV) isolates can be broadly classified as type 1 or type 2 on the basis of allelic polymorphism of the virus-encoded nuclear antigens EBNAs 2, 3a, 3b and 3c, and individually identified based on Mr values of their EBNA proteins (EBNA type). Here we have used this natural heterogeneity amongst isolates to re-examine the question of EBV persistence in vivo, asking in particular whether virus carriage in oropharyngeal epithelium and/or in B lymphoid tissues involves infection with a single or with multiple virus strains. Firstly, 76 healthy virus carriers were classified into serotype groups on the basis of preferential antibody reactivity to type 1 EBNAs (serotype 1) or to type 2 EBNAs (serotype 2); 60 of the 76 donors were serotype 1, four of the 76 donors were serotype 2 and 12 of the 76 donors were anti-EBNA 2, 3a, 3b, 3c antibody-negative and therefore could not be serotyped. Representative donors from each group were then selected for virus isolations from blood (by spontaneous in vitro transformation) and from throat washings (by cord blood cell transformation). All 13 serotype 1 donors tested and six of seven non-serotypeable donors gave a type 1 virus isolate, whereas all four serotype 2 donors and one of the seven non-serotypeable donors gave a type 2 isolate. Multiple transforming virus isolates from any one donor, whether from blood or throat washings, were all of the one strain characteristic of that particular donor; sequential isolations showed retention of the same strain over several years. Finally, throat washing samples from these same donors were examined for amplifiable EBV DNA in the polymerase chain reaction using EBV type-specific oligonucleotide primers and probes derived from the polymorphic EBNA 2 and EBNA 3c loci. The results were consistent with earlier virus isolation studies, each individual donor showing amplification either of type 1 or type 2 sequences. We conclude that multiple EBV infections must occur rarely, if at all, in healthy virus carriers; EBV persistence in vivo is characterized by dominance of a single transforming virus strain.
Received 4 February 1991;
accepted 22 March 1991.
This article has been cited by other articles:
|
|
 |
|
  G. N. DeLorenze, K. L. Munger, E. T. Lennette, N. Orentreich, J. H. Vogelman, and A. Ascherio Epstein-Barr Virus and Multiple Sclerosis: Evidence of Association From a Prospective Study With Long-term Follow-up Arch Neurol, June 1, 2006; 63(6): 839 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Walling, A. L. Brown, W. Etienne, W. A. Keitel, and P. D. Ling Multiple Epstein-Barr Virus Infections in Healthy Individuals J. Virol., June 1, 2003; 77(11): 6546 - 6550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Tao, J. Yang, H. Huang, L. J. Swinnen, and R. F. Ambinder Conservation of Epstein-Barr Virus Cytotoxic T-Cell Epitopes in Posttransplant Lymphomas : Implications for Immune Therapy Am. J. Pathol., May 1, 2002; 160(5): 1839 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Palefsky, J. Berline, D. Greenspan, and J. S. Greenspan Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes J. Gen. Virol., February 1, 2002; 83(2): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L S Young, C W Dawson, and A G Eliopoulos The expression and function of Epstein-Barr virus encoded latent genes Mol. Pathol., October 1, 2000; 53(5): 238 - 247. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Hopwood and D. H Crawford The role of EBV in post-transplant malignancies: a review J. Clin. Pathol., April 1, 2000; 53(4): 248 - 254. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Srivastava, K. Y. Wong, A. K. S. Chiang, K. Y. Lam, and Q. Tao Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state Blood, April 1, 2000; 95(7): 2443 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brooks, D. S. G. Croom-Carter, A. M. Leese, R. J. Tierney, G. Habeshaw, and A. B. Rickinson Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains J. Virol., February 15, 2000; 74(4): 1801 - 1809. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Midgley, N. W. Blake, Q. Y. Yao, D. Croom-Carter, S. T. Cheung, S. F. Leung, A. T. C. Chan, P. J. Johnson, D. Huang, A. B. Rickinson, et al. Novel Intertypic Recombinants of Epstein-Barr Virus in the Chinese Population J. Virol., February 1, 2000; 74(3): 1544 - 1548. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. Aguirre and E. S. Robertson Epstein-Barr Virus Recombinants from BC-1 and BC-2 Can Immortalize Human Primary B Lymphocytes with Different Levels of Efficiency and in the Absence of Coinfection by Kaposi's Sarcoma-Associated Herpesvirus J. Virol., January 1, 2000; 74(2): 735 - 743. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-G. Cho, A. V. Gordadze, P. D. Ling, and F. Wang Evolution of Two Types of Rhesus Lymphocryptovirus Similar to Type 1 and Type 2 Epstein-Barr Virus J. Virol., November 1, 1999; 73(11): 9206 - 9212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. van Baarle, E. Hovenkamp, M. J. Kersten, M. R. Klein, F. Miedema, and M. H.J. van Oers Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Blood, June 1, 1999; 93(11): 3949 - 3955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Habeshaw, Q. Y. Yao, A. I. Bell, D. Morton, and A. B. Rickinson Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt's Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas J. Virol., February 1, 1999; 73(2): 965 - 975. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Y. Yao, D. S. G. Croom-Carter, R. J. Tierney, G. Habeshaw, J. T. Wilde, F. G. H. Hill, C. Conlon, and A. B. Rickinson Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort J. Virol., May 1, 1998; 72(5): 4352 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dolcetti, P. Zancai, V. De Re, A. Gloghini, B. Bigoni, B. Pivetta, S. De Vita, A. Carbone, and M. Boiocchi Epstein-Barr Virus Strains With Latent Membrane Protein-1 Deletions: Prevalence in the Italian Population and High Association With Human Immunodeficiency Virus-Related Hodgkin's Disease Blood, March 1, 1997; 89(5): 1723 - 1731. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
